Active Interferon Alpha 13 (IFNa13)
LeIF D; Interferon alpha-D
- Product No.APG970Hu01
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- Buffer Formulation20mM Tris, 150mM NaCl, pH8.0, containing 1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose and Proclin300.
- Traits Freeze-dried powder
- Purity> 90%
- Isoelectric Pointn/a
- ApplicationsCell culture; Activity Assays.
- Downloadn/a
- UOM 10µg50µg 200µg 1mg 5mg
- FOB
US$ 320
For more details, please contact local distributors! US$ 800 US$ 1600 US$ 4800 US$ 12000
ACTIVITY TEST
USAGE
Reconstitute in 20mM Tris, 150mM NaCl (PH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
STORAGE
Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
GIVEAWAYS
INCREMENT SERVICES
- BCA Protein Quantification Kit
- Molecular Mass Marker for Protein
- Monoclonal Antibody Customized Service
- Polyclonal Antibody Customized Service
- Protein Activity Test Experiment Service
- Electrophoretic Mobility Shift Assay (EMSA) Experiment Service
- Buffer
- Lentivirus Packaging Experiment Service
- Adenovirus Packaging Experiment Service
- Real Time PCR Experimental Service
- Spike RBD Protein (S-RBD)
- Protein G
- Protein A
Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
APG970Hu61 | Active Interferon Alpha 13 (IFNa13) | Cell culture; Activity Assays. |
APG970Hu01 | Active Interferon Alpha 13 (IFNa13) | Cell culture; Activity Assays. |
EPG970Hu61 | Eukaryotic Interferon Alpha 13 (IFNa13) | Positive Control; Immunogen; SDS-PAGE; WB. |
RAG970Hu21 | Recombinant Antibody to Interferon Alpha 13 (IFNa13) | WB; IF; ICC; IHC; IP; FCM. |